J. Anthony Ware - 23 Dec 2025 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Reporting relationship: Director
Issuer ticker: ANAB
Reported as of: 23 Dec 2025
Net transaction value: -$193,342
SEC form: 4
Accepted by SEC: 23 Dec 2025, 16:30:22 UTC
Prior SEC filing: 17 Jun 2025
Next SEC filing: 08 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Eric Loumeau, Attorney-in-Fact

Key filing fact

J. Anthony Ware filed Form 4 for ANAPTYSBIO, INC (ANAB) on 23 Dec 2025.

Key facts

This page summarizes J. Anthony Ware's Form 4 filing for ANAPTYSBIO, INC (ANAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Dec 2025, 16:30.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: -$193,342.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001715429 Primary reporting owner

Ware J. Anthony

Relationship: Director
Address: C/O ANAPTYSBIO, INC., 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Signature date: 23 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANAB transaction

Common Stock

Sale

Transaction value: $193,342
Shares: -3,900
Change %: -29%
Price: $49.58
Shares after: 9,630
Date: 23 Dec 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

In addition to the shares the Reporting Person owns reported in Table I, the Reporting Person also holds additional options to purchase up to an aggregate of 126,085 shares of common stock and 6,030 restricted stock units.